Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Reljanovic GT"'
Autor:
Gritti G; Hematology Unit, Azienda Socio Sanitario Territoriale Papa Giovanni XXIII, Bergamo, Italy. g.gritti@asst-pg23.it., Raimondi F; Pneumology Unit, Azienda Socio Sanitario Territoriale Papa Giovanni XXIII, Bergamo, Italy.; Postgraduate School of Respiratory Medicine, University of Milan, Milan, Italy., Bottazzi B; Humanitas Clinical and Research Center - IRCCS, Milan, Italy., Ripamonti D; Infectious Diseases Unit, Azienda Socio Sanitario Territoriale Papa Giovanni XXIII, Bergamo, Italy., Riva I; Intensive Care Unit, Azienda Socio Sanitario Territoriale Papa Giovanni XXIII, Bergamo, Italy., Landi F; Hematology Unit, Azienda Socio Sanitario Territoriale Papa Giovanni XXIII, Bergamo, Italy.; Postgraduate School of Hematology, University of Milan, Milan, Italy., Alborghetti L; Infectious Diseases Unit, Azienda Socio Sanitario Territoriale Papa Giovanni XXIII, Bergamo, Italy., Frigeni M; Hematology Unit, Azienda Socio Sanitario Territoriale Papa Giovanni XXIII, Bergamo, Italy., Damiani M; Intensive Care Unit, Azienda Socio Sanitario Territoriale Papa Giovanni XXIII, Bergamo, Italy.; Postgraduate School of Anesthesiology and Intensive Care, University of Milan, Milan, Italy., Micò C; Hematology Unit, Azienda Socio Sanitario Territoriale Papa Giovanni XXIII, Bergamo, Italy., Fagiuoli S; Gastroenterology Unit, Azienda Socio Sanitario Territoriale Papa Giovanni XXIII, Bergamo, Italy., Lorini FL; Intensive Care Unit, Azienda Socio Sanitario Territoriale Papa Giovanni XXIII, Bergamo, Italy., Gandini L; Intensive Care Unit, Azienda Socio Sanitario Territoriale Papa Giovanni XXIII, Bergamo, Italy.; Postgraduate School of Anesthesiology and Intensive Care, University of Milan, Milan, Italy., Novelli L; Pneumology Unit, Azienda Socio Sanitario Territoriale Papa Giovanni XXIII, Bergamo, Italy., Morgan JP; EUSA Pharma, Hemel Hempstead, UK., Owens BMJ; EUSA Pharma, Hemel Hempstead, UK., Kanhai KJK; EUSA Pharma, Hemel Hempstead, UK., Reljanovic GT; ErgoMed PLC, Guildford, UK., Rizzi M; Infectious Diseases Unit, Azienda Socio Sanitario Territoriale Papa Giovanni XXIII, Bergamo, Italy., Di Marco F; Pneumology Unit, Azienda Socio Sanitario Territoriale Papa Giovanni XXIII, Bergamo, Italy.; Department of Health Sciences, University of Milan, Milan, Italy., Mantovani A; Postgraduate School of Respiratory Medicine, University of Milan, Milan, Italy.; Department of Biomedical Sciences, Humanitas University, Milan, Italy.; The William Harvey Research Institute, Queen Mary University of London, London, UK., Rambaldi A; Hematology Unit, Azienda Socio Sanitario Territoriale Papa Giovanni XXIII, Bergamo, Italy.; Department of Oncology-Hematology, University of Milan, Milan, Italy.
Publikováno v:
Leukemia [Leukemia] 2021 Sep; Vol. 35 (9), pp. 2710-2714. Date of Electronic Publication: 2021 May 24.
Autor:
Gritti G; Hematology Unit, Azienda Socio Sanitario Territoriale Papa Giovanni XXIII, Bergamo, Italy. g.gritti@asst-pg23.it., Raimondi F; Pneumology Unit, Azienda Socio Sanitario Territoriale Papa Giovanni XXIII, Bergamo, Italy.; Postgraduate School of Respiratory Medicine, University of Milan, Milan, Italy., Bottazzi B; Humanitas Clinical and Research Center - IRCCS, Milan, Italy., Ripamonti D; Infectious Diseases Unit, Azienda Socio Sanitario Territoriale Papa Giovanni XXIII, Bergamo, Italy., Riva I; Intensive Care Unit, Azienda Socio Sanitario Territoriale Papa Giovanni XXIII, Bergamo, Italy., Landi F; Hematology Unit, Azienda Socio Sanitario Territoriale Papa Giovanni XXIII, Bergamo, Italy.; Postgraduate School of Hematology, University of Milan, Milan, Italy., Alborghetti L; Infectious Diseases Unit, Azienda Socio Sanitario Territoriale Papa Giovanni XXIII, Bergamo, Italy., Frigeni M; Hematology Unit, Azienda Socio Sanitario Territoriale Papa Giovanni XXIII, Bergamo, Italy., Damiani M; Intensive Care Unit, Azienda Socio Sanitario Territoriale Papa Giovanni XXIII, Bergamo, Italy.; Postgraduate School of Anesthesiology and Intensive Care, University of Milan, Milan, Italy., Micò C; Hematology Unit, Azienda Socio Sanitario Territoriale Papa Giovanni XXIII, Bergamo, Italy., Fagiuoli S; Gastroenterology Unit, Azienda Socio Sanitario Territoriale Papa Giovanni XXIII, Bergamo, Italy., Lorini FL; Intensive Care Unit, Azienda Socio Sanitario Territoriale Papa Giovanni XXIII, Bergamo, Italy., Gandini L; Intensive Care Unit, Azienda Socio Sanitario Territoriale Papa Giovanni XXIII, Bergamo, Italy.; Postgraduate School of Anesthesiology and Intensive Care, University of Milan, Milan, Italy., Novelli L; Pneumology Unit, Azienda Socio Sanitario Territoriale Papa Giovanni XXIII, Bergamo, Italy., Morgan JP; EUSA Pharma, Hemel Hempstead, UK., Owens BMJ; EUSA Pharma, Hemel Hempstead, UK., Kanhai KJK; EUSA Pharma, Hemel Hempstead, UK., Reljanovic GT; ErgoMed PLC, Guildford, UK., Rizzi M; Infectious Diseases Unit, Azienda Socio Sanitario Territoriale Papa Giovanni XXIII, Bergamo, Italy., Di Marco F; Pneumology Unit, Azienda Socio Sanitario Territoriale Papa Giovanni XXIII, Bergamo, Italy.; Department of Health Sciences, University of Milan, Milan, Italy., Mantovani A; Humanitas Clinical and Research Center - IRCCS, Milan, Italy.; Department of Biomedical Sciences, Humanitas University, Milan, Italy.; The William Harvey Research Institute, Queen Mary University of London, London, UK., Rambaldi A; Hematology Unit, Azienda Socio Sanitario Territoriale Papa Giovanni XXIII, Bergamo, Italy.; Department of Oncology-Hematology, University of Milan, Milan, Italy.
Publikováno v:
Leukemia [Leukemia] 2021 Sep; Vol. 35 (9), pp. 2734.